Home / Cardiovascular Devices / Coagulation Factors 2011. Who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

Coagulation Factors 2011. Who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis

By: La Merie Publishing
Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis
 
Product description
 
The report Coagulation Factors 2011 who does meet the market needs? 
A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis provides a description, evaluation and assessment of the recombinant coagulation factor R&D pipelines as of October 2011. The authors analyze and assess the target pipeline for each of the coagulation factors for haemophilia and work out the target profiles of development projects. A market research study was conducted to challenge industrys target profiles and evaluate the sensitivity for pricing.
 
The report is built upon primary and secondary search for information and use of a proprietary database and news portal. A market survey was conducted among haematologists from haemophilia care centers. In house analysts with experience in biopharmaceutical R&D and business development authored the report and analysed and assessed the findings.
 
Global sales of the five major recombinant products of coagulation factors VIII, IX and VIIa in 2010 were US$ 6.2 bln (with $ conversion rate October 19, 2010). The first Marketing Authorization Application for a novel recombinant coagulation factor has been submitted in the European Union and further novel wild-type and long-acting recombinant coagulation factors VIII, IX and VII are in advanced clinical stages with potential regulatory approvals within the next 2 to 4 years. Given the progress of the pipeline, a concentration process of players has started. First clinical data are available and will guide further definition of R&D in this field.
 
Scope of the report
 
  • R&D pipeline overview;
  • profiles of most promising coagulation factors in the pipeline
  • pipeline analysis for each coagulation factor
  • evaluation and assessment of protein engineering and drug delivery technologies
  • overview and analysis of marketed coagulation factors;
  • market research study with haematologists from haemophilia care centers
  • corporate product portfolios and R&D pipelines;
  • benchmark of competitors regarding achievement of product target profiles
 
Benefits from the report
 
  • Understand your position in a highly competitive environment
  • Learn what haematologists think about your product target profiles
  • Understand the market needs
  • Know pricing sensitivities for your haemophilia products
  • Learn from your competitors
  • Challenge your strategy with a view from outside the organization

NA

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +